| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.0093 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0024 | 1 |